Target intelligence / Profile preview

Submucosal gland of respiratory tract

Molecular classification
Other (Glandular tissue; not a molecule or receptor)
01

Overview

Submucosal glands of the respiratory tract are specialized secretory glands located beneath the epithelial lining of medium and large airways, including the trachea and bronchi. These glands include both mucous and serous cell types within a tubuloacinar structure, connected to the airway surface via ducts. They produce and secrete large amounts of mucus composed of water, electrolytes, and mucin glycoproteins—primarily MUC5B, along with hundreds of proteins for airway protection[1][3][4][6]. Their main function is to maintain airway hydration, trap inhaled particles, and mediate mucociliary clearance. Dysfunction or hyperplasia of these glands contributes to the pathology of diseases such as cystic fibrosis (due to abnormal mucus viscosity and clearance), asthma, and chronic bronchitis[1][3][4]. Although some drugs (e.g., muscarinic antagonists, mucolytics) modify gland secretion, the "mucous gland" itself is not a single molecular target, but rather an anatomical and functional unit[1][3]. Key caveat: "Mucous gland of respiratory tract" is not the name of a discrete molecular target, enzyme, receptor, or transporter, but rather refers to a tissue structure comprised of multiple cell types and molecular pathways. For queries about molecular regulation or druggable targets within these glands, focus would shift to specific molecular components such as muscarinic receptors (e.g., M3) or mucin proteins (e.g., MUC5B)[2][6], which are genuine drug or research targets.

Other names
Submucosal glandairway submucosal glandbronchial glandairway glandsubmucosal mucous gland
02

Biological functions

Mucus secretionAirway surface liquid homeostasisHost defense (via secretion of protective proteins, antimicrobials)
03

Disease associations

Inflammation (e.g., chronic bronchitis, asthma)Infection (especially in cystic fibrosis)Obstructive lung diseases (e.g., cystic fibrosis, chronic obstructive pulmonary disease/COPD)
04

Safety considerations

Excess mucus (hypersecretion) can contribute to airway obstructionMucus stasis increases risk of infection and inflammation in obstructive diseases

Beyond the preview

Go deeper on Submucosal gland of respiratory tract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Submucosal gland of respiratory tract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call